Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1915 entries
Sorted by: Best Match Show Resources per page
Patient Medication Adherence and Physician Prescribing among Congestive Heart Failure Patients of Yemen.

Indian journal of pharmaceutical sciences

Alakhali KM, Daniel PS, Noohu AM, Sirajudeen SA.
PMID: 24403656
Indian J Pharm Sci. 2013 Sep;75(5):557-62.

Congestive heart failure has been associated with high morbidity and mortality requiring hospitalisation and is further complicated by noncompliance and under prescriptions. We aim to determine medication adherence and percentage deviation among Asians population in general and Yemenis in...

Cite
Alakhali KM, Daniel PS, Noohu AM, et al. Patient Medication Adherence and Physician Prescribing among Congestive Heart Failure Patients of Yemen. Indian J Pharm Sci. 2013;75(5):557-62
Alakhali, K. M., Daniel, P. S., Noohu, A. M., & Sirajudeen, S. A. (2013). Patient Medication Adherence and Physician Prescribing among Congestive Heart Failure Patients of Yemen. Indian journal of pharmaceutical sciences, 75(5), 557-62.
Alakhali, K M, et al. "Patient Medication Adherence and Physician Prescribing among Congestive Heart Failure Patients of Yemen." Indian journal of pharmaceutical sciences vol. 75,5 (2013): 557-62.
Alakhali KM, Daniel PS, Noohu AM, Sirajudeen SA. Patient Medication Adherence and Physician Prescribing among Congestive Heart Failure Patients of Yemen. Indian J Pharm Sci. 2013 Sep;75(5):557-62. PMID: 24403656; PMCID: PMC3877517.
Copy Download .nbib Format: NLM
Prevalence of tinnitus in patients withhypertension and the impact of different anti hypertensive drugs on the incidence of tinnitus: A prospective, single-blind, observational study.

Current therapeutic research, clinical and experimental

Borghi C, Brandolini C, Prandin MG, Dormi A, Modugno GC, Pirodda A.
PMID: 24790243
Curr Ther Res Clin Exp. 2005 Sep;66(5):420-32. doi: 10.1016/j.curtheres.2005.10.001.

BACKGROUND: Tinnitus is a common symptom in audiology and neurologypatients. Controversial data have been reported in the literature about the prevalence of tinnitus in hypertensive patients, whereas its relationship with the extent of blood pressure (BP) control has not...

Cite
Borghi C, Brandolini C, Prandin MG, et al. Prevalence of tinnitus in patients withhypertension and the impact of different anti hypertensive drugs on the incidence of tinnitus: A prospective, single-blind, observational study. Curr Ther Res Clin Exp. 2005;66(5):420-32doi: 10.1016/j.curtheres.2005.10.001.
Borghi, C., Brandolini, C., Prandin, M. G., Dormi, A., Modugno, G. C., & Pirodda, A. (2005). Prevalence of tinnitus in patients withhypertension and the impact of different anti hypertensive drugs on the incidence of tinnitus: A prospective, single-blind, observational study. Current therapeutic research, clinical and experimental, 66(5), 420-32. https://doi.org/10.1016/j.curtheres.2005.10.001
Borghi, Claudio, et al. "Prevalence of tinnitus in patients withhypertension and the impact of different anti hypertensive drugs on the incidence of tinnitus: A prospective, single-blind, observational study." Current therapeutic research, clinical and experimental vol. 66,5 (2005): 420-32. doi: https://doi.org/10.1016/j.curtheres.2005.10.001
Borghi C, Brandolini C, Prandin MG, Dormi A, Modugno GC, Pirodda A. Prevalence of tinnitus in patients withhypertension and the impact of different anti hypertensive drugs on the incidence of tinnitus: A prospective, single-blind, observational study. Curr Ther Res Clin Exp. 2005 Sep;66(5):420-32. doi: 10.1016/j.curtheres.2005.10.001. PMID: 24790243; PMCID: PMC4003803.
Copy Download .nbib Format: NLM
Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study.

Current therapeutic research, clinical and experimental

Sekuri C, Bayturan O, Gocer H, Tavli T, Tezcan UK.
PMID: 24944419
Curr Ther Res Clin Exp. 2003 Nov;64(9):715-24. doi: 10.1016/j.curtheres.2003.11.005.

BACKGROUND: Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a diuretic has been shown to be highly effective in hypertension. Clinical trials have demonstrated that ACE inhibitors may improve endothelial cell dysfunction in hypertension. However, the effectiveness of...

Cite
Sekuri C, Bayturan O, Gocer H, et al. Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study. Curr Ther Res Clin Exp. 2003;64(9):715-24doi: 10.1016/j.curtheres.2003.11.005.
Sekuri, C., Bayturan, O., Gocer, H., Tavli, T., & Tezcan, U. K. (2003). Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study. Current therapeutic research, clinical and experimental, 64(9), 715-24. https://doi.org/10.1016/j.curtheres.2003.11.005
Sekuri, Cevad, et al. "Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study." Current therapeutic research, clinical and experimental vol. 64,9 (2003): 715-24. doi: https://doi.org/10.1016/j.curtheres.2003.11.005
Sekuri C, Bayturan O, Gocer H, Tavli T, Tezcan UK. Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study. Curr Ther Res Clin Exp. 2003 Nov;64(9):715-24. doi: 10.1016/j.curtheres.2003.11.005. PMID: 24944419; PMCID: PMC4053063.
Copy Download .nbib Format: NLM
Antihypertensive drug prescription pattern before and during pregnancy in France.

Pregnancy hypertension

Duhalde V, Delarue C, Lacroix I, Suarez C, Bourrel R, Montastruc JL, Damase-Michel C.
PMID: 26104501
Pregnancy Hypertens. 2011 Apr;1(2):185-9. doi: 10.1016/j.preghy.2011.01.001. Epub 2011 Feb 01.

OBJECTIVE: This study provides firsthand information on antihypertensive prescriptions before and during pregnancy in France.METHODS: The study, on 23,898 women, was carried out using data from the French Health Insurance System.RESULTS: Before and during pregnancy, 1.1% and 5.1% of...

Cite
Duhalde V, Delarue C, Lacroix I, et al. Antihypertensive drug prescription pattern before and during pregnancy in France. Pregnancy Hypertens. 2011;1(2):185-9doi: 10.1016/j.preghy.2011.01.001.
Duhalde, V., Delarue, C., Lacroix, I., Suarez, C., Bourrel, R., Montastruc, J. L., & Damase-Michel, C. (2011). Antihypertensive drug prescription pattern before and during pregnancy in France. Pregnancy hypertension, 1(2), 185-9. https://doi.org/10.1016/j.preghy.2011.01.001
Duhalde, Veronique, et al. "Antihypertensive drug prescription pattern before and during pregnancy in France." Pregnancy hypertension vol. 1,2 (2011): 185-9. doi: https://doi.org/10.1016/j.preghy.2011.01.001
Duhalde V, Delarue C, Lacroix I, Suarez C, Bourrel R, Montastruc JL, Damase-Michel C. Antihypertensive drug prescription pattern before and during pregnancy in France. Pregnancy Hypertens. 2011 Apr;1(2):185-9. doi: 10.1016/j.preghy.2011.01.001. Epub 2011 Feb 01. PMID: 26104501.
Copy Download .nbib Format: NLM
Underrated value of repeated right heart catheterization in pulmonary hypertension with heart failure-a case of persisted pulmonary arterial hypertension after treatment for biventricular failure.

Journal of thoracic disease

Park S, Yoon HY, Jeung S, Lee NK, Kim MS, Ahn JM, Kim DH, Lee JS.
PMID: 26623126
J Thorac Dis. 2015 Oct;7(10):E489-92. doi: 10.3978/j.issn.2072-1439.2015.10.09.

Pulmonary hypertension (PH) is a common complication of left heart disease and its presence in patients with heart failure predicts worse clinical outcomes. Specific agents targeting pulmonary arterial hypertension (PAH) have been developed over the last few years, but...

Cite
Park S, Yoon HY, Jeung S, et al. Underrated value of repeated right heart catheterization in pulmonary hypertension with heart failure-a case of persisted pulmonary arterial hypertension after treatment for biventricular failure. J Thorac Dis. 2015;7(10):E489-92doi: 10.3978/j.issn.2072-1439.2015.10.09.
Park, S., Yoon, H. Y., Jeung, S., Lee, N. K., Kim, M. S., Ahn, J. M., Kim, D. H., & Lee, J. S. (2015). Underrated value of repeated right heart catheterization in pulmonary hypertension with heart failure-a case of persisted pulmonary arterial hypertension after treatment for biventricular failure. Journal of thoracic disease, 7(10), E489-92. https://doi.org/10.3978/j.issn.2072-1439.2015.10.09
Park, Shinhee, et al. "Underrated value of repeated right heart catheterization in pulmonary hypertension with heart failure-a case of persisted pulmonary arterial hypertension after treatment for biventricular failure." Journal of thoracic disease vol. 7,10 (2015): E489-92. doi: https://doi.org/10.3978/j.issn.2072-1439.2015.10.09
Park S, Yoon HY, Jeung S, Lee NK, Kim MS, Ahn JM, Kim DH, Lee JS. Underrated value of repeated right heart catheterization in pulmonary hypertension with heart failure-a case of persisted pulmonary arterial hypertension after treatment for biventricular failure. J Thorac Dis. 2015 Oct;7(10):E489-92. doi: 10.3978/j.issn.2072-1439.2015.10.09. PMID: 26623126; PMCID: PMC4635302.
Copy Download .nbib Format: NLM
Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Pharmaceuticals (Basel, Switzerland)

Hörl WH.
PMID: 27713354
Pharmaceuticals (Basel). 2010 Jul 21;3(7):2291-2321. doi: 10.3390/ph3072291.

Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the isoenzymes COX-1 and COX-2 of cyclooxygenase (COX). Renal side effects (e.g., kidney function, fluid and urinary electrolyte excretion) vary with the extent of COX-2-COX-1 selectivity and the administered dose of these compounds. While...

Cite
Hörl WH. Nonsteroidal Anti-Inflammatory Drugs and the Kidney. Pharmaceuticals (Basel). 2010;3(7):2291-2321doi: 10.3390/ph3072291.
Hörl, W. H. (2010). Nonsteroidal Anti-Inflammatory Drugs and the Kidney. Pharmaceuticals (Basel, Switzerland), 3(7), 2291-2321. https://doi.org/10.3390/ph3072291
Hörl, Walter H. "Nonsteroidal Anti-Inflammatory Drugs and the Kidney." Pharmaceuticals (Basel, Switzerland) vol. 3,7 (2010): 2291-2321. doi: https://doi.org/10.3390/ph3072291
Hörl WH. Nonsteroidal Anti-Inflammatory Drugs and the Kidney. Pharmaceuticals (Basel). 2010 Jul 21;3(7):2291-2321. doi: 10.3390/ph3072291. PMID: 27713354; PMCID: PMC4036662.
Copy Download .nbib Format: NLM
Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia.

Annals of intensive care

Oude Lansink-Hartgring A, Hessels L, Weigel J, de Smet AMGA, Gommers D, Panday PVN, Hoorn EJ, Nijsten MW.
PMID: 26983857
Ann Intensive Care. 2016 Dec;6(1):22. doi: 10.1186/s13613-016-0124-x. Epub 2016 Mar 17.

BACKGROUND: Dysnatremia is associated with adverse outcome in critically ill patients. Changes in patients or treatment strategies may have affected the incidence of dysnatremia over time. We investigated long-term changes in the incidence of dysnatremia and analyzed its association...

Cite
Oude Lansink-Hartgring A, Hessels L, Weigel J, et al. Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia. Ann Intensive Care. 2016;6(1):22doi: 10.1186/s13613-016-0124-x.
Oude Lansink-Hartgring, A., Hessels, L., Weigel, J., de Smet, A. M. G. A., Gommers, D., Panday, P. V. N., Hoorn, E. J., & Nijsten, M. W. (2016). Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia. Annals of intensive care, 6(1), 22. https://doi.org/10.1186/s13613-016-0124-x
Oude Lansink-Hartgring, Annemieke, et al. "Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia." Annals of intensive care vol. 6,1 (2016): 22. doi: https://doi.org/10.1186/s13613-016-0124-x
Oude Lansink-Hartgring A, Hessels L, Weigel J, de Smet AMGA, Gommers D, Panday PVN, Hoorn EJ, Nijsten MW. Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia. Ann Intensive Care. 2016 Dec;6(1):22. doi: 10.1186/s13613-016-0124-x. Epub 2016 Mar 17. PMID: 26983857; PMCID: PMC4794471.
Copy Download .nbib Format: NLM
Ultrasound Assessment of Kidney Volume in Patients with Acute Decompensated Heart Failure: A Predictor of Diuretic Resistance.

Yonago acta medica

Sugihara S, Kinugasa Y, Takata T, Sugihara T, Hosho K, Imai C, Ito H, Yamada K, Kato M, Yamamoto K.
PMID: 28959123
Yonago Acta Med. 2017 Sep 15;60(3):135-144. eCollection 2017 Sep.

BACKGROUND: Diuretics are essential for treating acute decompensated heart failure (ADHF), but the response is inconsistent. This study aimed to clarify whether kidney volume as assessed by ultrasound (US) predicts diuretic resistance in patients with ADHF.METHODS: We enrolled 29...

Cite
Sugihara S, Kinugasa Y, Takata T, et al. Ultrasound Assessment of Kidney Volume in Patients with Acute Decompensated Heart Failure: A Predictor of Diuretic Resistance. Yonago Acta Med. 2017;60(3):135-144
Sugihara, S., Kinugasa, Y., Takata, T., Sugihara, T., Hosho, K., Imai, C., Ito, H., Yamada, K., Kato, M., & Yamamoto, K. (2017). Ultrasound Assessment of Kidney Volume in Patients with Acute Decompensated Heart Failure: A Predictor of Diuretic Resistance. Yonago acta medica, 60(3), 135-144.
Sugihara, Shinobu, et al. "Ultrasound Assessment of Kidney Volume in Patients with Acute Decompensated Heart Failure: A Predictor of Diuretic Resistance." Yonago acta medica vol. 60,3 (2017): 135-144.
Sugihara S, Kinugasa Y, Takata T, Sugihara T, Hosho K, Imai C, Ito H, Yamada K, Kato M, Yamamoto K. Ultrasound Assessment of Kidney Volume in Patients with Acute Decompensated Heart Failure: A Predictor of Diuretic Resistance. Yonago Acta Med. 2017 Sep 15;60(3):135-144. eCollection 2017 Sep. PMID: 28959123; PMCID: PMC5611467.
Copy Download .nbib Format: NLM
Impact of Cardiorenal Anemia Syndrome on Short- and Long-Term Clinical Outcomes in Patients Hospitalized with Heart Failure.

Cardiorenal medicine

Kim CJ, Choi IJ, Park HJ, Kim TH, Kim PJ, Chang K, Baek SH, Chung WS, Seung KB.
PMID: 27648008
Cardiorenal Med. 2016 Aug;6(4):269-78. doi: 10.1159/000443339. Epub 2016 Apr 28.

BACKGROUND: Dysfunctional interplay between the heart and kidneys may lead to the development of anemia. The aim of this study was to evaluate the impact of cardiorenal anemia syndrome (CRAS) on short- and long-term outcomes among patients hospitalized with...

Cite
Kim CJ, Choi IJ, Park HJ, et al. Impact of Cardiorenal Anemia Syndrome on Short- and Long-Term Clinical Outcomes in Patients Hospitalized with Heart Failure. Cardiorenal Med. 2016;6(4):269-78doi: 10.1159/000443339.
Kim, C. J., Choi, I. J., Park, H. J., Kim, T. H., Kim, P. J., Chang, K., Baek, S. H., Chung, W. S., & Seung, K. B. (2016). Impact of Cardiorenal Anemia Syndrome on Short- and Long-Term Clinical Outcomes in Patients Hospitalized with Heart Failure. Cardiorenal medicine, 6(4), 269-78. https://doi.org/10.1159/000443339
Kim, Chan Joon, et al. "Impact of Cardiorenal Anemia Syndrome on Short- and Long-Term Clinical Outcomes in Patients Hospitalized with Heart Failure." Cardiorenal medicine vol. 6,4 (2016): 269-78. doi: https://doi.org/10.1159/000443339
Kim CJ, Choi IJ, Park HJ, Kim TH, Kim PJ, Chang K, Baek SH, Chung WS, Seung KB. Impact of Cardiorenal Anemia Syndrome on Short- and Long-Term Clinical Outcomes in Patients Hospitalized with Heart Failure. Cardiorenal Med. 2016 Aug;6(4):269-78. doi: 10.1159/000443339. Epub 2016 Apr 28. PMID: 27648008; PMCID: PMC5020385.
Copy Download .nbib Format: NLM
Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data.

Clinical hypertension

Choi SI, Kim SK, Park S, Kim JH, Ihm SH, Kim GI, Kim WS, Pyun WB, Kim YM, Shin J.
PMID: 26893941
Clin Hypertens. 2016 Jan 27;22:8. doi: 10.1186/s40885-016-0045-x. eCollection 2015.

BACKGROUND: Resistant hypertension (RH) may be one of the cause of the plateau in improving the control rate in hypertension (HT) management. The misdiagnosis of RH by clinic blood pressure (BP) is important clinical problem. Aim of the study...

Cite
Choi SI, Kim SK, Park S, et al. Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data. Clin Hypertens. 2016;22:8doi: 10.1186/s40885-016-0045-x.
Choi, S. I., Kim, S. K., Park, S., Kim, J. H., Ihm, S. H., Kim, G. I., Kim, W. S., Pyun, W. B., Kim, Y. M., & Shin, J. (2015). Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data. Clinical hypertension, 228. https://doi.org/10.1186/s40885-016-0045-x
Choi, Sung Il, et al. "Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data." Clinical hypertension vol. 22 (2015): 8. doi: https://doi.org/10.1186/s40885-016-0045-x
Choi SI, Kim SK, Park S, Kim JH, Ihm SH, Kim GI, Kim WS, Pyun WB, Kim YM, Shin J. Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data. Clin Hypertens. 2016 Jan 27;22:8. doi: 10.1186/s40885-016-0045-x. eCollection 2015. PMID: 26893941; PMCID: PMC4750808.
Copy Download .nbib Format: NLM
High prevalence of primary dyslipidaemia in black South African patients at a tertiary hospital in northern Gauteng, South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Khine AA, Marais DA.
PMID: 27384370
S Afr Med J. 2016 Jun 17;106(7):724-9. doi: 10.7196/SAMJ.2016.v106i7.10337.

BACKGROUND: The prevalence of cardiovascular disease is projected to be 38.7% for the USA in 2020, including coronary heart disease at 8.6% and stroke at 3.6%. In South Africa (SA), premature deaths due to heart and blood vessel diseases...

Cite
Khine AA, Marais DA. High prevalence of primary dyslipidaemia in black South African patients at a tertiary hospital in northern Gauteng, South Africa. S Afr Med J. 2016;106(7):724-9doi: 10.7196/SAMJ.2016.v106i7.10337.
Khine, A. A., & Marais, D. A. (2016). High prevalence of primary dyslipidaemia in black South African patients at a tertiary hospital in northern Gauteng, South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 106(7), 724-9. https://doi.org/10.7196/SAMJ.2016.v106i7.10337
Khine, Aye Aye, and Marais, David Adrian. "High prevalence of primary dyslipidaemia in black South African patients at a tertiary hospital in northern Gauteng, South Africa." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde vol. 106,7 (2016): 724-9. doi: https://doi.org/10.7196/SAMJ.2016.v106i7.10337
Khine AA, Marais DA. High prevalence of primary dyslipidaemia in black South African patients at a tertiary hospital in northern Gauteng, South Africa. S Afr Med J. 2016 Jun 17;106(7):724-9. doi: 10.7196/SAMJ.2016.v106i7.10337. PMID: 27384370.
Copy Download .nbib Format: NLM
Impact of sweating on equivalent dose of patients treated with (131)Iiodine.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Haghighatafshar M, Banani A, Gheisari F, Alikhani M.
PMID: 27385884
Indian J Nucl Med. 2016 Jul-Sep;31(3):172-5. doi: 10.4103/0972-3919.183613.

BACKGROUND: Radioiodine therapy is used for the treatment of patients with differentiated thyroid cancer (DTC) who undergo total thyroidectomy. After radioiodine administration, regulations require to quarantine these patients until their retained activity reduces to

Cite
Haghighatafshar M, Banani A, Gheisari F, et al. Impact of sweating on equivalent dose of patients treated with (131)Iiodine. Indian J Nucl Med. 2016;31(3):172-5doi: 10.4103/0972-3919.183613.
Haghighatafshar, M., Banani, A., Gheisari, F., & Alikhani, M. (2016). Impact of sweating on equivalent dose of patients treated with (131)Iiodine. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 31(3), 172-5. https://doi.org/10.4103/0972-3919.183613
Haghighatafshar, Mahdi, et al. "Impact of sweating on equivalent dose of patients treated with (131)Iiodine." Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India vol. 31,3 (2016): 172-5. doi: https://doi.org/10.4103/0972-3919.183613
Haghighatafshar M, Banani A, Gheisari F, Alikhani M. Impact of sweating on equivalent dose of patients treated with (131)Iiodine. Indian J Nucl Med. 2016 Jul-Sep;31(3):172-5. doi: 10.4103/0972-3919.183613. PMID: 27385884; PMCID: PMC4918477.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1915 entries